- Home
- RAYA vs GRCE Comparison
RAYA vs GRCE Comparison
Compare RAYA & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- GRCE
- Stock Information
- Founded
- RAYA 2019
- GRCE 2002
- Country
- RAYA China
- GRCE United States
- Employees
- RAYA N/A
- GRCE N/A
- Industry
- RAYA Metal Fabrications
- GRCE
- Sector
- RAYA Consumer Discretionary
- GRCE
- Exchange
- RAYA Nasdaq
- GRCE NYSE
- Market Cap
- RAYA 103.6M
- GRCE 42.1M
- IPO Year
- RAYA 2022
- GRCE N/A
- Fundamental
- Price
- RAYA $3.07
- GRCE $3.21
- Analyst Decision
- RAYA
- GRCE Strong Buy
- Analyst Count
- RAYA 0
- GRCE 1
- Target Price
- RAYA N/A
- GRCE $12.00
- AVG Volume (30 Days)
- RAYA 792.5K
- GRCE 64.1K
- Earning Date
- RAYA 01-01-0001
- GRCE 08-15-2025
- Dividend Yield
- RAYA N/A
- GRCE N/A
- EPS Growth
- RAYA N/A
- GRCE N/A
- EPS
- RAYA N/A
- GRCE N/A
- Revenue
- RAYA $30,300,360.00
- GRCE N/A
- Revenue This Year
- RAYA $20.95
- GRCE N/A
- Revenue Next Year
- RAYA N/A
- GRCE N/A
- P/E Ratio
- RAYA N/A
- GRCE N/A
- Revenue Growth
- RAYA 49.10
- GRCE N/A
- 52 Week Low
- RAYA $0.56
- GRCE $1.75
- 52 Week High
- RAYA $3.20
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- RAYA 67.66
- GRCE N/A
- Support Level
- RAYA $1.77
- GRCE N/A
- Resistance Level
- RAYA $2.99
- GRCE N/A
- Average True Range (ATR)
- RAYA 0.49
- GRCE 0.00
- MACD
- RAYA 0.03
- GRCE 0.00
- Stochastic Oscillator
- RAYA 86.67
- GRCE 0.00
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.